Skip to main content
    V

    Varex Imaging Corp (VREX)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $18.10
    -0.03 (-0.17%)

    Market Cap: $768.59M

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Varex Imaging Corp (VREX) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    Varex Imaging (VREX) has a market cap of $768.59M and an enterprise value of $1.02B. Its trailing P/E is 16.8x.

    Total Valuation

    Enterprise value is 32.25% above the market cap, as debt exceeds cash.

    Market Cap$768.59M
    Enterprise Value$1.02B
    Latest price (Nov 17, 2026)$18.10

    Key Dates

    The next earnings report is expected on Nov 24, 2026, covering the quarter ending Sep 30, 2026.

    Next Earnings DateNov 24, 2026 (expected)
    Last Earnings DateAug 10, 2026
    Fiscal Year EndSeptember

    Share Statistics

    The share count rose 0.24% in the quarter ended Jun 30, 2026 and grew 1.46% a year over 2 years.

    Shares Outstanding42.10M
    Shares Change (YoY)+1.45%
    Shares Change (QoQ)+0.24%
    Share Count Growth (2Y CAGR)+1.46%

    Valuation Ratios

    Sales and book value multiples are 0.9x and 1.5x. Its year-end P/E ranged from 11.7x to 26.1x from 2017 to 2025.

    P/E Ratio16.8x
    Forward P/E15.4x
    P/S Ratio0.9x
    Forward P/S0.9x
    P/B Ratio1.5x
    P/TBV Ratio2.7x
    P/OCF Ratio68.0x
    PEG Ratio2.0

    Valuation history and multiples

    Enterprise Valuation

    Counting debt and cash, the company is valued at 10.9x EBITDA.

    EV / Earnings45.2x
    EV / Sales1.2x
    EV / EBITDA10.9x
    EV / EBIT16.0x

    Price Statistics

    The stock is up 51.85% over 52 weeks and trades 1.79% below its 50-day average.

    Beta (1Y)0.88
    52-Week Change+51.85%
    1-Month Change-1.63%
    3-Month Change-1.95%
    6-Month Change+94.21%
    5-Year Change-31.36%
    Total Return (1Y)+51.85%
    Total Return (3Y CAGR)-1.59%
    Total Return (5Y CAGR)-9.13%
    Return vs SPY (1Y)+41.05%
    Max Drawdown (1Y)-35.10%
    Max Drawdown (3Y)-67.84%
    Sharpe Ratio (1Y)0.75
    Correlation with SPY (1Y)0.22
    50-Day Average$18.43
    200-Day Average$13.86
    52-Week Range$9.09 to $18.63
    RSI (14 Days)29.9
    Average Volume (20 Days)700.59K

    The 5-year change compares month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 3.38x current liabilities, and total debt is 0.70x shareholder equity.

    Current Ratio3.38x
    Quick Ratio1.53x
    Debt / Equity0.70x
    Debt / EBITDA3.76x
    Interest Coverage1.64x

    Returns and Efficiency

    Return on invested capital is 6.12% over the last 12 months, against a 5-year average of 2.96%.

    Return on Equity (ROE)4.53%
    Return on Assets (ROA)2.05%
    Return on Invested Capital (ROIC)6.12%
    Return on Capital Employed (ROCE)6.97%
    ROE (5Y Average)-1.20%
    ROA (5Y Average)-0.46%
    ROIC (5Y Average)2.96%
    Asset Turnover0.80x
    Inventory Turnover1.64x
    Receivables Turnover5.91x
    Cash Conversion Cycle227 days

    Taxes

    Income tax took 18.77% of pretax income over the last 12 months.

    Income Tax (TTM)$5.20M
    Effective Tax Rate18.77%

    Scores

    VREX has an Altman Z-Score of 2.24, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 5 of 9, in the average band of 3 to 7.

    Altman Z-Score2.24
    Altman Z ZoneGrey
    Piotroski F-Score5 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $865.00M over the last 12 months is up 5.31% from the 12 months before.

    Revenue$865.00M
    Revenue Growth (YoY)+5.31%
    Gross Profit$296.90M
    Operating Income$72.20M
    Pretax Income$27.70M
    Net Income$22.50M
    EBITDA$92.40M
    EBIT$63.60M
    Reported EPS (TTM)$1.08

    Trailing 12 months through Jun 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 45.15% of the $1.10B in total assets.

    Cash and Equivalents$99.20M
    Total Debt$347.10M
    Net Debt$247.90M
    Net Debt Per Share$5.89
    Working Capital$445.70M
    Shareholder Equity$496.60M
    Book Value Per Share$11.80
    Tangible Book Value$286.60M
    Tangible Book Per Share$6.81
    Total Assets$1.10B
    Total Liabilities$589.50M

    Balance sheet as of Jun 30, 2026.

    Full balance sheet

    Cash Flow

    After $31.50M of capital spending, operating cash flow left -$20.20M of free cash flow.

    Operating Cash Flow$11.30M
    Capital Expenditures$31.50M
    Free Cash Flow-$20.20M
    FCF Per Share-$0.48
    Depreciation and Amortization$28.80M

    Trailing 12 months through Jun 30, 2026.

    Full cash flow statement

    Margins

    The operating margin is 8.35%, against a 5-year average of 5.72%.

    Gross Margin34.32%
    Operating Margin8.35%
    Pretax Margin3.20%
    Net Margin2.60%
    EBITDA Margin10.68%
    EBIT Margin7.35%
    FCF Margin-2.34%
    Gross Margin (5Y Average)32.95%
    Operating Margin (5Y Average)5.72%
    Net Margin (5Y Average)-0.62%

    Growth

    Revenue fell 0.58% a year over 3 years, and EPS 18.05% a year.

    Revenue Growth (3Y CAGR)-0.58%
    Revenue Growth (5Y CAGR)+2.73%
    EPS Growth (3Y CAGR)-18.05%
    EPS Growth (5Y CAGR)-11.12%
    Book Value Per Share Growth (2Y CAGR)+0.29%
    Tangible Book Per Share Growth (2Y CAGR)+10.64%

    Revenue and profit by year

    Dividends and Yields

    VREX does not pay a dividend. Its free cash flow yield is -2.65%.

    Earnings Yield5.95%
    FCF Yield-2.65%
    Buyback Yield-0.21%
    Shareholder Yield-0.21%

    Peer Position

    Against 8 similar companies, VREX has the 5th highest P/E and the 2nd highest ROIC.

    P/E Ratio16.8x vs 17.4x median
    P/S Ratio0.9x vs 3.4x median
    ROIC6.12% vs -4.43% median
    Revenue Growth (Trailing 4 Quarters, YoY)+5.31% vs +14.00% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put EPS growth at 50.70% a year over the next fiscal year.

    EPS Growth Forecast (1Y CAGR)+50.70%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About VREX

    What is VREX's market cap?

    Varex Imaging has a market cap of $768.59M. Its enterprise value, which adds debt and subtracts cash, is $1.02B.

    What is VREX's P/E ratio?

    Varex Imaging has a trailing P/E ratio of 16.8x and a forward P/E of 15.4x.

    How many shares of VREX are outstanding?

    Varex Imaging has 42.10M shares outstanding. The count is up 1.45% from a year earlier.

    Does VREX pay a dividend?

    No. Varex Imaging does not pay a dividend.

    How much debt does VREX have?

    Varex Imaging has $347.10M of total debt and $99.20M of cash and equivalents, a net debt position of $247.90M.